Letter: Resistant pseudomonads in a neurosurgical unit.
D000617:Aminoglycosides / Q000494:pharmacology / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use; D001437:Bacteriuria / Q000175:diagnosis; D002228:Carbenicillin / Q000494:pharmacology / Q000627:therapeutic use; D002264:Carboxylic Acids / Q000627:therapeutic use; D003428:Cross Infection / Q000188:drug therapy* / Q000382:microbiology; D005839:Gentamicins / Q000494:pharmacology / Q000627:therapeutic use; D006757:Hospital Units; D006801:Humans; D009493:Neurosurgery; D010403:Penicillin Resistance; D010406:Penicillins / Q000031:analogs & derivatives / Q000627:therapeutic use; D011183:Postoperative Complications; D011552:Pseudomonas Infections / Q000188:drug therapy* / Q000382:microbiology / Q000652:urine; D011550:Pseudomonas aeruginosa / Q000187:drug effects* / Q000302:isolation & purification; D013876:Thiophenes / Q000627:therapeutic use; D014546:Urinary Catheterization
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D002264:Carboxylic Acids; D005839:Gentamicins; D010406:Penicillins; D013876:Thiophenes; D002228:Carbenicillin